Ipamorelin Research
Selective Growth Hormone Secretagogue
Research area: growth hormone signaling
Ipamorelin is a selective, third-generation pentapeptide growth hormone releasing peptide (GHRP) studied for its activity at GHSR (growth hormone secretagogue receptor) signaling pathways. It is distinguished in research for its high GH-release selectivity with minimal effect on cortisol or prolactin.
Research Areas
GHSR Signaling Research
Research focuses on Ipamorelin's binding selectivity at the growth hormone secretagogue receptor (GHSR-1a) and its downstream signaling cascade leading to pituitary GH release without significant crosstalk to cortisol or prolactin pathways.
Growth Hormone Pulse Research
Studies examine how Ipamorelin influences the amplitude and frequency of GH secretion pulses and its relationship to downstream IGF-1 production signaling in liver and peripheral tissues.
Body Composition & Metabolic Pathways
Research investigates Ipamorelin's influence on fat oxidation signaling, lean tissue preservation pathways, and metabolic rate-related cellular processes.
Growth hormone secretagogue research; investigational compound.
Research References
Discuss any health concerns with a licensed clinician before making health decisions.
Have questions about Ipamorelin?
Request a free consultation to ask questions and learn more about this research area.
Affiliate disclosure: I am an independent affiliate of The Longevity Consultants and may receive compensation if you request a consultation through me.
Request a free consultation